49 results on '"Dorai, Thambi"'
Search Results
2. Metabolic Heterogeneity, Plasticity and Adaptation to “Gluta-mine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase – ω-Amidase (Glutaminase II)] Pathway.
3. Role of Glutamine Transaminases in Nitrogen, Sulfur, Selenium, and 1-Carbon Metabolism
4. α-Ketoglutaramate—A key metabolite contributing to glutamine addiction in cancer cells
5. ω-Amidase: an underappreciated, but important enzyme in l-glutamine and l-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases
6. The metabolic importance of the overlooked asparaginase II pathway
7. The metabolic importance of the glutaminase II pathway in normal and cancerous cells
8. Amelioration of Renal Ischemia-Reperfusion Injury With a Novel Protective Cocktail
9. Role of Glutamine Transaminases in Nitrogen, Sulfur, Selenium, and 1-Carbon Metabolism
10. Hypoxic pre-conditioning in a rat renal ischemia model: an evaluation of the use of hydralazine
11. INDUCTION OF HYPOMETABOLISM AS A NOVEL STRATEGY TO EXTEND WARM ISCHEMIA TIME IN PARTIAL NEPHRECTOMIES: MP29-09
12. Erratum to: ω-Amidase: an underappreciated, but important enzyme in l-glutamine and l-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases
13. ADMINISTRATION OF A UNIQUE RENOPROTECTIVE COCKTAIL IN A RAT MODEL: CAN WARM ISCHEMIA-REPERFUSION INJURY BE PREVENTED?: 842
14. Microvesicles and exosomes in pulmonary hypertension
15. High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in ‘Glutamine Addiction’
16. Role of chemopreventive agents in cancer therapy
17. Book review
18. High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in 'Glutamine Addiction'.
19. Abstract B003: NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis
20. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP‐C4‐2B prostate cancer model of progressive metastasis
21. TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVO
22. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo
23. Sweetening of glutamine metabolism in cancer cells by Rho GTPases through convergence of multiple oncogenic signaling pathways
24. Abstract A11: Downregulation of NRH:quinone oxidoreductase 2(NQO2) in the LNCaP prostate cancer progression model system: Implications to metastasis
25. Kynurenine Aminotransferase III and Glutamine Transaminase L Are Identical Enzymes that have Cysteine S-Conjugate β-Lyase Activity and Can Transaminate l-Selenomethionine
26. MP29-09 INDUCTION OF HYPOMETABOLISM AS A NOVEL STRATEGY TO EXTEND WARM ISCHEMIA TIME IN PARTIAL NEPHRECTOMIES
27. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 <i>in Vivo</i>
28. Selective transamination of Se‐methyl‐L‐selenocysteine (MSC) and L‐selenomethionine (SM) by glutamine transaminase (GT) K and L, respectively.
29. The Administration of Renoprotective Agents Extends Warm Ischemia in a Rat Model
30. 310 EVALUATION OF A NOVEL STRATEGY TO EXTEND WARM ISCHEMIA TIME IN COMPLEX PARTIAL NEPHRECTOMIES
31. 842 ADMINISTRATION OF A UNIQUE RENOPROTECTIVE COCKTAIL IN A RAT MODEL: CAN WARM ISCHEMIA-REPERFUSION INJURY BE PREVENTED?
32. 366 CARBONIC ANHYDRASE IX SHEDDING THROUGH EXOSOMES IN RENAL CARCINOMA CELLS
33. Role of Carbonic Anhydrases in the Progression of Renal Cell Carcinoma Subtypes: Proposal of a Unified Hypothesis
34. The role of carbonic anhydrase IX overexpression in kidney cancer
35. Clonal Isolation of Different Strains of Mouse Mammary Tumor Virus-Like DNA Sequences from Both the Breast Tumors and Non-Hodgkin’s Lymphomas of Individual Patients Diagnosed with Both Malignancies
36. Therapeutic potential of curcumin in prostate cancer?IV: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells
37. DNA Repair in Cancer Therapy
38. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo
39. A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells
40. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer
41. Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium
42. Cleavage of human MDR 1 mRNA by a hammerhead ribozyme
43. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis.
44. Cleavage of human MDR1 mRNA by a hammerhead ribozyme
45. The Structurally Distinct Form of pp60c-src Detected in Neuronal Cells Is Encoded by a Unique c-src mRNA
46. Nucleotide sequence of a cDNA for the chickyesproto-oncogene: comparison with the viralyesgene
47. Nucleotide sequence of a cDNA for the chick yes proto-oncogene: comparison with the viral yesgene.
48. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo.
49. Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.